Fatty Infiltration of Liver in Hyperlipidemic Patients

Digestive Diseases and Sciences - Tập 45 - Trang 1929-1934 - 2000
Nimer Assy1, Kelly Kaita1, David Mymin1, Clifford Levy1, Barry Rosser1, Gerald Minuk1
1Liver Diseases Unit and Lipid Clinic, Departments of Medicine and Radiology, University of Manitoba, Winnipeg, Canada

Tóm tắt

Hyperlipidemia is a known risk factor for fatty infiltration of the liver, a condition that can progress to cirrhosis and liver failure. The objectives of this study were to document the prevalence of fatty infiltration in the livers of hyperlipidemic patients and to identify the predictor variables associated with this condition. Over an 18-month recruitment period, clinical, biochemical, and radiologic assessments were performed in a cross-sectional manner in 95 adult patients referred to an urban hospital-based lipid clinic for evaluation and management of hyperlipidemia. The mean (±sd) age of the patients was 55 ± 13 years. Forty-eight (51%) were male. Fifty-two patients (55%) had hypercholesterolemia, 25 (26%) severe hypertriglyceridemia, 14 (15%) mixed hyperlipidemia, and 4 (4%) moderate hypertriglyceridemia. Obesity and diabetes were present in 36 (38%) and 12 (12%) of cases, respectively. A total of 61 (64%) patients had elevated liver enzyme tests. The most common enzyme abnormalities were an elevated serum ALT in 45 (47%) and GGT in 43 (45%) of patients. Ultrasound findings revealed diffuse fatty liver in 47 patients (50%), of which 21 cases (22%) were mild, 18 (19%) moderate, and 8 (9%) severe. The majority of patients with hypercholesterolemia [35/52 (67%)] had normal ultrasounds, whereas severe hypertriglyceridemia and mixed hyperlipidemia were frequently associated with radiologic evidence of fatty liver (odds ratios 5.9 and 5.1 respectively, P < 0.01). Independent predictors of fatty liver were; AST (P = 0.001), hyperglycemia (P = 0.02), and age (P = 0.04). In a model incorporating known risk factors for fatty liver, diabetes was the only risk factor other than hypertriglyceridemia that was significantly associated with fatty infiltration. No such effect was seen with age, gender, obesity, or alcohol consumption. In conclusions, the results of this study indicate that ultrasonographic evidence of fatty infiltration of the liver is evident in approximately 50% of patients with hyperlipidemia. Hypertriglyceridemia is the lipid profile most often associated with this condition. Serum AST values, hyperglycemia, and age independently predict the presence of fatty infiltration, while hypertriglyceridemia and diabetes are the only risk factors that significantly increase the risk of fatty infiltration in hyperlipidemic patients.

Từ khóa


Tài liệu tham khảo

Alpers DH, Sabesin SM, White HM: Fatty liver: biochemical and clinical aspects. In Disease of the Liver, 7th ed. L Schiff and ER Schiff (eds). Philadelphia, JB Lippincott, 1993, pp 825-855

Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis. Mayo clinical experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434-438, 1980

Alder M, Schaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67:811-816, 1979

Anon: Report of the National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults. Arch Intern Med 148:36-39, 1988

Anon: The International Committee for the Evaluation of Hypertriglyceridemia as a Vascular Risk Factor. The hypertriglyceridemias: Risk and management. Am J Cardiol 68:1A-42A, 1991

Friedewald WT, Levy RJ, Frederickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preoperative ultracentrifuge. Clin Chem 18:499-502, 1972

Marz W, Serkmeier R, Gross W, Kostner GM: Determination of lipoprotein (a): evaluation of three methods. Eur J Clin Chem Clin Biochem 31:295-302, 1993

Willey DG, Rosenthal MA, Caldwell S: Glycosylated hemoglobin and plasma glycoprotein assays by affinity chromatography. Diabetologia 27:56-58, 1984

Scatarige JC, Scott WE, Donovan PJ, et al: Fatty infiltration of the liver. Ultrasonographic and computed tomographic correlation. J Ultrasound Med 3:9-14, 1984

Scott WW, Sanders RC, Siegelman SS: Irregular fatty infiltration of the liver, diagnostic dilemmas. AJR 135:67-71, 1980

Williamson DF: Descriptive epidemiology of body weight and change in US adults. Ann Intern Med 119:646-649, 1993

O'Hare JA, Weir GC: Insulin therapy. In Principles and Practice of Endocrinology and Metabolism. KL Becker, et al (eds). Philadelphia, JB Lippincott, 1990, pp 1102-1109

Saveryumuttu SH, Joseph AEA, Maxwell JD: Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 292:13-15, 1986

Hultcrantz R, Gabrielsson N: Patients with persistent elevation of aminotransferases: Investigation with ultrasonography, radionuclide imaging and liver biopsy. J Intern Med 233:7-12, 1993

Joseph AEA, Saverymuttu SH, AI-Sam S, Cook MG, Maxwell JD: Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43:26-31, 1991

Layer G, Zuna I, Lorenz A, Zerban H, Haberkorn U, Bannasch P, van Kaick G, Rath U: Computerized ultrasound B-scan texture analysis of experimental diffuse parenchymal liver disease: Correlation with histopathology and tissue composition. J Clin Ultrasound 19:193-201, 1999

Cavouras D, Kandarakis I, Theotokas I, Kanellopoulos E, Triantis D, Behrakis I, Manesisi EK, Vafiadi-Zoumpouli I, Zoumpoulis P: Computer image analysis of ultrasound images for discriminating and grading liver parenchyma disease employing a hierarchical decision tree scheme and the multilayer perception neural network classifier. Stud Health Technol Inform 43:522-526, 1997

Mendler MH, Bouillet P, Le Sidaner A, Lavoine E, Labrousse F, Sautereau D, Pillegand B: Dual-energy CT in the diagnosis and quantification of fatty liver: Limited clinical value in comparison to ultrasound scan and single-energy CT, with special reference to iron overload. J Hepatol 28:785-794, 1998

Davies RJ, Saverymuttu SH, Fallowfield M, Joseph AE: Paradoxical lack of ultrasound attenuation with gross fatty change in the liver. Clin Radiol 43:393-396, 1991

Ochs A, Rottler RM, Scholmerich J: Clinical relevance of abnormal liver findings with ultrasound. Hepatogastroenterology 41:9-15, 1994

Glickman RM, Sabesin SM. Lipoprotein metabolism. In The Liver: Biology and Pathobiology. 3rd ed. IM Arias, JL Boyer, N Fausto, WB Jacoby, DA Schachter, DA Shafritz (eds). New York, Raven Press, 1994, pp 391-414

Bengmark S: Liver steatosis and liver resection. Digestion 2:304, 1969

Stone BG, Van Thiel TH: Diabetes mellitus and the liver. Semin Liver Dis 5:8-28, 1985

Clain DJ, Lefkowitch JH: Fatty liver disease in morbid obesity. Gastroenterol Clin North Am 16:239-252, 1987

Bjortorp P: Regional obesity and NIDDM. In New Concepts in the Pathogenesis of NIDDM. CG Ostenson, S Efendic, M Vranic (eds). New York, Plenum Press, 1993, pp 279-285

Steiner G. Hyperinsulinaemia and hypertriglyceridemia. J Intern Med 236:23-26, 1994

Reaven GM: The role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988

Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM: Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 94:2557-2562, 1997

Galambos JT, Willis CE: Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 74:1191-1199, 1978

Savolainen VT, Liesto K, Mannikko A, Penttila A, Karhunen PJ: Alcohol consumption and alcoholic liver disease: Evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 17(5):1112-1117, 1993

Thông tin
Thông tin xuất bản

Digestive Diseases and Sciences

Tập 45

1929-1934

Thông tin tác giả